Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- After 26 Stakes Wins, Fan Favorite Ben's Cat Retired
- Copper Bullet Out to Build Reputation in Bashford Manor
- New York Discusses Race-Day Lasix Rules
- Hill 'n' Dale Acquires Half Interest in Bubbler
- Industry Groups Ask for Change in Parx Oaks Ruling
- Fager to Deliver Thoroughbred Owner Conference Keynote
- Ward Pleased With Stable's Royal Ascot Performance
- Arrogate Breezes at Santa Anita
- Conrad Bandoroff Joins Denali Stud
- Irap Gets Best of Girvin in Ohio Derby